Detalhe da pesquisa
1.
N-Glycosylation of the Ig Receptors Shapes the Antigen Reactivity in Chronic Lymphocytic Leukemia Subset #201.
J Immunol
; 211(5): 743-754, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466373
2.
Levels of IgE sensitization drive symptom thresholds in allergic rhinitis.
Ann Allergy Asthma Immunol
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679157
3.
A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece.
Medicina (Kaunas)
; 60(5)2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38792965
4.
Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study.
J Clin Immunol
; 43(6): 1259-1271, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036560
5.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36314897
6.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol
; 98(12): 1856-1868, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772428
7.
The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects.
Int J Mol Sci
; 24(18)2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762410
8.
Insufficient weight loss after banded vs. non-banded primary gastric bypass surgery: insights from an observational 5 year follow-up study.
Surg Endosc
; 36(8): 5964-5969, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981228
9.
A chemometric approach for the differentiation of 15 monofloral honeys based on physicochemical parameters.
J Sci Food Agric
; 102(1): 139-146, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056719
10.
Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers.
Medicina (Kaunas)
; 58(10)2022 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36295492
11.
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Br J Haematol
; 192(6): 978-987, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862447
12.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870594
13.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood
; 133(11): 1205-1216, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602617
14.
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study.
Allergy
; 76(10): 3041-3052, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492738
15.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583077
16.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523289
17.
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
Medicina (Kaunas)
; 57(8)2021 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34441032
18.
"Whole" vs. "fragmented" approach to EAACI pollen season definitions: A multicenter study in six Southern European cities.
Allergy
; 75(7): 1659-1671, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833579
19.
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study.
Am J Hematol
; 95(4): 362-371, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868245
20.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096887